Hospital
Cah Acquisition Company 11 LLC
Cah Acquisition Company 11 LLC was paid $1.39M by Medicaid between Jan 2018 and Aug 2021, across 71 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoCAH ACQUISITION COMPANY 11 LLC
RIPLEY, TN 38063
RIPLEY, TN 38063
33aNPI1932421401assigned 02/24/2010
33bProvider typeCritical Access Hospital
28Total paid$1.39M
24GClaims44,269
24DCodes billed71
24AFirst – last monthJan 2018 – Aug 2021
Compared with peers
Next to other Critical Access Hospital providers in Tennessee
Rank by total paid#9 of 15
Median peer was paid$1.48M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,458 | $553K | |
| 2019 | 11,478 | $336K | |
| 2020 | 11,079 | $418K | |
| 2021 | 4,254 | $84K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 6,680 | 4,560 | $485K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 4,855 | 3,171 | $458K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 1,480 | 901 | $175K |
| 80053 | Comprehensive metabolic panel | 4.5% | 4,294 | 3,433 | $63K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.5% | 6,005 | 4,789 | $49K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 1,621 | 1,313 | $20K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,567 | 5,194 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,473 | 1,244 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 835 | 669 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 526 | 436 | $12K |
| 81001 | <1% | 2,891 | 2,373 | $10K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,113 | 891 | $10K |
59 more codes
| 84484 | <1% | 622 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 510 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 143 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 287 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 155 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 47 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 346 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 560 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 137 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 229 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 198 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 367 | $2K |
| 83735 | <1% | 261 | $2K | |
| 74022 | <1% | 38 | $2K | |
| 83874 | <1% | 167 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 205 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 129 | $761.80 |
| 84100 | <1% | 109 | $710.97 | |
| 82150 | <1% | 35 | $664.39 | |
| 83605 | <1% | 40 | $543.60 | |
| 86769 | <1% | 60 | $505.56 | |
| 87040 | <1% | 26 | $489.76 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 110 | $485.21 |
| 81025 | <1% | 62 | $331.82 | |
| 83880 | <1% | 13 | $303.51 | |
| 85014 | <1% | 126 | $296.88 | |
| 83690 | <1% | 35 | $285.07 | |
| 30000 | <1% | 15 | $280.21 | |
| 80061 | Lipid panel | <1% | 82 | $274.16 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 131 | $261.51 |
| J2704 | Injection, propofol, 10 mg | <1% | 76 | $255.13 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $246.83 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $193.92 |
| 94664 | <1% | 20 | $193.03 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $163.84 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 31 | $152.09 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 19 | $142.84 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 29 | $112.50 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 17 | $109.06 |
| G0378 | Hospital observation service, per hour | <1% | 30 | $101.35 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $98.36 |
| 85610 | <1% | 15 | $86.28 | |
| 85730 | <1% | 15 | $85.66 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16 | $81.60 |
| 80358 | 0% | 27 | $0.00 | |
| 80359 | 0% | 27 | $0.00 | |
| 80345 | 0% | 26 | $0.00 | |
| 80349 | 0% | 13 | $0.00 | |
| 80368 | 0% | 13 | $0.00 | |
| 80353 | 0% | 26 | $0.00 | |
| 80324 | 0% | 27 | $0.00 | |
| 80356 | 0% | 27 | $0.00 | |
| 80369 | 0% | 26 | $0.00 | |
| 80337 | 0% | 13 | $0.00 | |
| 80346 | 0% | 27 | $0.00 | |
| 80364 | 0% | 27 | $0.00 | |
| 80372 | 0% | 13 | $0.00 | |
| 80348 | 0% | 27 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAYFIELD, MICHAEL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Cah Acquisition Company 11 LLC | Ripley, TN | $80K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.